In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore

OBJECTIVE: Carbapenem-resistant Acinetobacter baumannii (CR-AB) is an emerging cause of nosocomial infections worldwide. Combination therapy may be the only viable option until new antibiotics become available. The objective of this study is to identify potential antimicrobial combinations against C...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lim, Tze-Peng, Tan, Thean-Yen, Lee, Winnie, Sasikala, S., Tan, Thuan-Tong, Hsu, Li-Yang, Kwa, Andrea L.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2011
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3080872/
https://ncbi.nlm.nih.gov/pubmed/21533030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0018485
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares